Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
QuintilesIMS
Cipla
Fish and Richardson
Baxter
Boehringer Ingelheim
Julphar
McKinsey
Citi

Generated: May 27, 2018

DrugPatentWatch Database Preview

LOTUSATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Lotusate, and what generic alternatives are available?

Lotusate is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in LOTUSATE is talbutal. Additional details are available on the talbutal profile page.
Summary for LOTUSATE
Drug patent expirations by year for LOTUSATE
Synonyms for LOTUSATE
(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione
115-44-6
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylpropyl)-5-(2-propenyl)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methypropyl)-5-(2-propenyl)-
5-(1-Methylpropyl)-5-(2-propen-1-yl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-(1-methylpropyl)-5-(2-propenyl)-2,4,6(1''H'',3''H'',5''H'')-pyrimidinetrione
5-(1-Methylpropyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-(1-methylpropyl)-5-prop-2-en-1-ylpyrimidine-2,4,6(1H,3H,5H)-trione
5-Allyl-5-(1-methylpropyl) barbituric acid
5-Allyl-5-sec-butyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Allyl-5-sec-butylbarbituric acid
5-butan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
5-Isobutyl-5-allylbarbituric acid
API0009188
Barbituric acid, 5-allyl-5-sec-butyl-
BJVVMKUXKQHWJK-UHFFFAOYSA-N
CAS-115-44-6
CHEBI:134923
CS-7222
D0W0MF
DB00306
DR000452
DSSTox_CID_3630
DSSTox_GSID_23630
DSSTox_RID_97553
DTXSID8023630
EINECS 204-090-4
FT-0674795
HE298547
HSDB 3397
HY-U00276
Lotusate (TN)
NCGC00253567-01
Profundol
SCHEMBL122147
Sec-Butyl allylbarbituric acid
Talbumalum
TALBUTAL
Talbutal (INN)
Talbutal [INN]
Talbutal [USP:INN]
TALBUTAL CIII (250 MG)
Talbutal ciii(250 mg)
Talbutale
Talbutale [DCIT]
Talbutalum
Talbutalum [INN-Latin]
Tox21_113715
WIN 5095

US Patents and Regulatory Information for LOTUSATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us LOTUSATE talbutal TABLET;ORAL 009410-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
McKesson
UBS
Moodys
Queensland Health
Cerilliant
US Army
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.